Super-enhancer mediated upregulation of MYEOV suppresses ferroptosis in lung adenocarcinoma

• Published in: Cancer letters 2024-05, Vol.589, p.216811-216811, Article 216811
• Main Authors: Luo, Shuimei, Luo, Yang, Wang, Ziming, Yin, Haofeng, Wu, Qing, Du, Xiaowei, Xie, Xianhe
• Format: Article
• Language: English
• Subjects: Ferroptosis; Lung adenocarcinoma; MYEOV; Super-enhancer
• ISSN: 0304-3835; 1872-7980
• DOI: 10.1016/j.canlet.2024.216811

Super-enhancers (SEs) exerted a crucial role in regulating the transcription of oncogenes across various malignancies while the roles of SEs driven genes and the core regulatory elements remain elusive in LUAD. In this study, cancer-specific-SE-genes of lung adenocarcinoma (LUAD) were profiled through H3K27ac ChIP-seq data of cancer cell lines and normal lung tissues, which enriched in in biological processes and pathways integral to the pathophysiology of LUAD. Based on this study, LUAD cells were susceptible to SEs inhibitors, with a reduction of cell proliferation as well as an elevation of apoptosis upon JQ1 or THZ1 intervention. Moreover, the integration of SEs landscapes, CRISPRi, ChIP-PCR, Hi-C data analysis and dual-luciferase reporter assays revealed that myeloma overexpressed gene (MYEOV) was aberrantly overexpressed in LUAD via transcriptional activation by the core SE elements. Functionally, the knockdown of MYEOV undermined cell proliferation in vitro and tumor growth in vivo. In addition, the knockdown of MYEOV generated a prominent ferroptotic phenotype, characterized by elevation of intracellular ferrous iron, reactive oxygen species and lipid peroxidation, together with alteration in marker proteins (SLC7A11, GPX4, FTH1, and ACSL4). Instead, the overexpression of MYEOV accelerated cell proliferation and abrogated ferroptosis. Clinically, the overexpression of MYEOV was observed in LUAD tissues indicating a poor prognosis in patients with LUAD. Mechanistically, SMPD1-induced autophagic degradation of GPX4 assumed a crucial role in the process of ferroptosis triggered by MYEOV knockdown. Serving as an oncogene repressing ferroptosis, promoting proliferation as well as shortening survival in LUAD, SEs-mediated activation of MYEOV might distinguish as a promising therapeutic target. •The overexpression of MYEOV in lung adenocarcinoma was driven by super-enhancer.•The knockdown of MYEOV facilitated ferroptosis in lung adenocarcinoma.•SMPD1-induced degradation of GPX4 assumed a crucial role in the process of ferroptosis triggered by MYEOV knockdown.